Wenyin Shi, MD
Enriched profileProfessor, Department of Radiation Oncology, Thomas Jefferson University; Medical Director of Radiation Oncology at Jefferson Hospital for Neuroscience (JHN) · Thomas Jefferson University
Wenyin Shi is Professor, Department of Radiation Oncology, Thomas Jefferson University; Medical Director of Radiation Oncology at Jefferson Hospital for Neuroscience (JHN) at Thomas Jefferson University. OpenAlex indexes 375 publications with 6,193 citations (h-index 35); ClinicalTrials.gov lists 13 registered studies with this person as an investigator.
Data verified 25 Oct 2026
Overview
Updated 27 Oct 2026
Wenyin Shi, MD, PHD, is Professor, Department of Radiation Oncology, Thomas Jefferson University. The public record shows 375 publications with 6,193 citations (h-index 35), centered on Glioma Diagnosis and Treatment, Advanced Radiotherapy Techniques, Brain Metastases and Treatment. It also documents an investigator role on 13 registered clinical trials, industry payments reported by 11 companies, 1 NIH-funded awards (2026–2026).
- Most recent indexed publication: 2026 · Journal of neuro-oncology
- Top research focus: Glioma Diagnosis and Treatment
- 13 registered trials on ClinicalTrials.gov
- Open Payments reporting from 11 companies
Generated from the cited public record · current as of 27 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 22 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 103.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 26 Oct 2026
Listed as an investigator on 13 registered studies on ClinicalTrials.gov. The most recent:
- 68Ga-Dotatate PET and MRI Guided Radiation Dose Escalation for High Risk Meningioma
Sponsor: Thomas Jefferson University
- Stereotactic Body Radiation Therapy and Aflibercept in Treating Patients With Uveal Melanoma
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Industry payments
Updated 26 Oct 2026
11 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Siemens Medical Solutions USA, Inc.Program year202512 payments
- Novocure Inc.Program year20252 payments
- Medtronic, Inc.Program year20253 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
77.8%Corticosteroid77.8%Dexamethasone100%Part D≥28 patientsNervous system
22.2%Benzodiazepine22.2%Lorazepam100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 26 Oct 2026
1 NIH research award on record, funded 2026–2026 per NIH RePORTER. The latest:
- Sidney Kimmel Cancer Center LAPS Institutional Collaboration
Thomas Jefferson University
FY2026$544,790UG1CA233341
Congress activity
Updated 26 Oct 2026
70 congress contributions (2007–2026) across AACR, ASCO, ASTRO, ESMO per OpenAlex. The most recent:
- A phase II study of neoadjuvant cemiplimab in hedgehog inhibitor (HHI)–naive basal cell carcinoma of the head and neck.
ASCO Annual Meeting
ASCO2026Co-author - Neoadjuvant cemiplimab in cutaneous basal cell carcinoma of the head and neck.
ASCO Annual Meeting
ASCO2025Co-author - Multi-institutional study of reirradiation for recurrent high grade glioma.
ASCO Annual Meeting
ASCO2024Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 26 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Feasibility evaluation of tumor treating fields for brainstem gliomas.
Journal of neuro-oncology
Article2026 - Metformin exposure after glioblastoma diagnosis and mortality: A large population-based study.
Neuro-oncology advances
Article2026 - Single-cell RNA sequencing suggests different progenitor lineages between IDH mutant and IDHwt glioma.
Neuro-oncology advances
Article2026 - Pituitary Macroadenoma and Adamantinomatous Craniopharyngioma: A Rare Case Report of Sellar Collision Tumors.
Case reports in neurological medicine
Case Report2025
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiformeArticle225 citations2014
- 04Advanced magnetic resonance imaging in glioblastoma: a reviewArticle213 citations2017
- 05
Network
Updated 26 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 26 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/wenyin-shi-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
jefferson.edu/academics/colleges-schools-institutes/skmc/departments/radiation-oncology/faculty/directory/shi.html
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jefferson.edu ↗ - Other
profiles.jefferson.edu/display/32960
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.jefferson.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 26 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jefferson.edu ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jefferson.edu ↗
Editorial & leadership roles
journal and society appointments- Guest Editor
Neuro-oncology focused issue, Chinese Clinical Oncology (2017), with Joshua D. Palmer
2017verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cco.amegroups.org ↗ - Editorial Board Member
Chinese Clinical Oncology
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cco.amegroups.org ↗ - Associate Editor
Radiation Oncology section, Frontiers in Oncology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →frontiersin.org ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cco.amegroups.org ↗
Secondary affiliations
appointments beyond the home institution- Department of Neurological Surgery
Thomas Jefferson University (professor)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cco.amegroups.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cco.amegroups.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
David Whellan, MD
Thomas Jefferson University
Jesse Roman, MD
Thomas Jefferson University
Stephen Silberstein, MD
Thomas Jefferson University
David Cognetti, MD
Thomas Jefferson University
Guy McKhann, MD
Emory University School of Medicine
Patrick Wen, MD
Dana-Farber Cancer Institute
Minesh Mehta, MD
Florida International University Herbert Wertheim College of Medicine
Timothy Cloughesy, MD
Ronald Reagan UCLA Medical Center